Abstract
Corticosteroids are currently used for primary and secondary adrenal insufficiency, but many medical conditions benefit from their use in view of their anti-inflammatory and immunosuppressive activity. Several mechanisms are involved in the anti-inflammatory action of glucocorticoids, and many remain to be elucidated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Packard BD, Weiler JM (1983) Steroids inhibit activation of the alternative amplification pathway of complement. Infect Immunol 40: 1011–1019
Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Eng J Med 329: 2002–2012
Hammerschmidt DE, White JG, Graddock PR, et al (1979) Corticosteroids inhibit complement-induced granulocyte aggregation: A possible mechanism for their efficacy in shock states. J Clin Invest 63: 798–803
Skubits KM, Craddock LR, Hammerschmidt DE, et al (1981) Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro. J Clin Invest 68: 13–20
Dhainaut JF, Mira JP (1993) Mediators of sepsis. The role of platelet activating factors in sepsis. In: Baumgartner JD, Calandra T, Carlet J (eds). Pathophysiology to therapeutic approaches. Maurice rapid Colloquia. Flammarion, Paris, pp 112–120
Beutler B, Krochin N, Milsark I, et al (1986) Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 232: 977–980
Parant M, Le Contel C, Parant F, et al (1991) Influence of endogenous glucocorticoid on endotoxin-induced production of circulating TNF-alpha. Lymphokine Cytokine Res 10: 265–271
Bernard GR, Artigas A, et al (1994) The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818–824
Hudson LD, Steinberg KP (1998) Acute respiratory distress syndrome: Clinical features, management and outcome. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Keiser LR, Senior RM (eds) Fishman’s Pulmonary Diseases and Disorders, 3rd edn. McGraw-Hill, New York, pp 2549–2565
Asbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2: 319–323
McConn R, Del Guercio LRM (1971) Respiratory function of blood in the acutely ill patient and the effect of steroids. Ann Surg 174: 436–450
Lozman J, Dutton RE, English M, Powers SR (1975) Cardiopulmonary adjustments following single high dose administration of methylprednisolone in traumatized man. Ann Surg 181: 317–324
Kusajima K, Wax SD, Web WR (1974) Effects of methylprednisolone on pulmonary microcirculation. Surg Gynecol Obstet 139: 1–5
Brigham KL, Bowers R, McKeen CR (1981) Methylprednisolone prevention of increased lung vascular permeability following in endotoxemia sheep. J Clin Invest 67: 1103–1110
Sladen A (1976) Methylprednisolone: pharmacologic dose in shock lung syndrome. J Thorac Cardiovasc Surg 71: 800–806
Lucas CE, Ledgerwood AM (1981) Pulmonary response of massive steroids in seriously injured patients. Ann Surg 194: 256–261
Sibbald WJ, Anderson RR, Reid B, Hollidah RC, Driedger AA (1981) Alveolo-capillary permeability in human septic ARDS: effect of high dose corticosteroid therapy. Chest 79: 133–142
Weigelt JA, Norcross JF, Borman KR, Snyder WH (1985) Early steroid therapy for respiratory failure. Arch Surg 120: 536–540
Bernard GR, Luce JM, Sprung CL, et al (1987) High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317: 1565–1570
Elias JA, Freundlich B, Kern JA, Rosenbloom J (1990) Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 97: 1439–1445
Raponi GM, Antonelli M, Gaeta A, et al (1992) Tumor necrosis factor in serum and bronchoalveolar lavage of patients at risk for ARDS. J Crit Care 7: 183–188
Meduri GU, Headley S, Kohler G, et al (1995) Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1ß and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107: 1062–1073
Antonelli M, Raponi GM, Martino P, et al (1995) High IL-6 serum levels are associated with septic shock and mortality in septic patients with severe leukopenia due to hematological malignancies. Scand J Infect Dis 27: 381–384
Kiehl MG, Ostermann H, Thomas M, Muller C, Cassens U, Kienast J (1998) Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Grit Care Med 26: 1194–1199
Montgomery AB, Stager MA, Carrico CJ, Hudson LD (1985) Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 132: 485–489
Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, El Torky M, Leeper KV Jr (1991) Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest 100: 943–952
Andrews CP, Coalson JJ, Smith JD, Johanson WG (1981) Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest 80: 254–258
Ashbaugh DG, Maier RV (1985) Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Arch Surg 120: 530–535
Hooper RG, Kearl RA (1996) Established adult respiratory distress syndrome treated with corticosteroids. South Med J 89: 449–451
Meduri GU, Chinn AJ, Leeper KV, et al (1994) Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest 105: 1516–1527
Meduri GU, Headley S, Tolley E, Shelby M, Stentz F, Postlethwaite A (1995) Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest 108: 1315–1325
Meduri GU, Headley, Golden E, Carson SJ (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. A randomized clinical trial. JAMA 280: 159–165
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Antonelli, M., Conti, G., Proietti, R. (2000). Corticosteroids in the Acute Respiratory Distress Syndrome. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2000. Yearbook of Intensive Care and Emergency Medicine, vol 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-13455-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-13455-9_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-66830-5
Online ISBN: 978-3-662-13455-9
eBook Packages: Springer Book Archive